According to a recent study, a novel drug Saracatinib is more successful than earlier medications at preventing fibrogenic reactions in pulmonary fibrosis. Read more here: doi.org/10.116...
Негізгі бет Saracatinib Blocks Fibrotic Responses in Preclinical Models of Pulmonary Fibrosis
Пікірлер: 2